Truist Securities Maintains Buy on Progyny, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained its Buy rating on Progyny (NASDAQ:PGNY) but has lowered the price target from $46 to $37.
May 17, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities has maintained its Buy rating on Progyny but has lowered the price target from $46 to $37.
The Buy rating suggests continued confidence in the stock's potential, but the lowered price target indicates a more conservative outlook on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100